Early postoperative treatment of mastectomy scars using a fractional carbon dioxide laser: a randomized, controlled, split-scar, blinded study

Article information

Arch Plast Surg. 2021;48(4):347-352

Publication date (electronic) : 2021 July 15

doi : https://doi.org/10.5999/aps.2020.02495

Hyun Woo Shin, Sangwoo Suk, Seoung Wan Chae, Kun Chul Yoon, Junekyu Kim

Department of Plastic and Reconstructive Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea

Correspondence: Hyun Woo Shin Department of Plastic and Reconstructive Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul 03181, Korea Tel: +82-2-2001-2178 Fax: +82-2-2001-2177 E-mail: shw.shin@samsung.com

This article was presented as a poster at the 10th R&R forum on July 24-25, 2020.

Received 2020 December 18; Revised 2021 April 16; Accepted 2021 May 27.

Abstract

INTRODUCTION

Breast cancer is the most widespread type of cancer among women, affecting 2.1 million women each year and causing the most cancer-related deaths among women [1]. It has been estimated that 627,000 women died from breast cancer in 2018, accounting for about 15% of all cancer deaths in women [2]. The incidence of breast cancer is steadily increasing, with 22,550 new cases and 2,353 deaths reported in 2015, based on statistics from the Korea Central Cancer Registry [3]. Since the 5-year survival rate of women with breast cancer is relatively high, at 89% [1], breast reconstruction has become a crucially important part of the care plan for these patients, and the demand for post-mastectomy breast reconstruction is simultaneously increasing [4]. However, mastectomy leaves unsightly scarring, and cosmetically unappealing scars cause distress in patients [5]. In addition, there is growing concern about scarring and patients are increasingly focusing on cosmetic outcomes. Thus, the proper treatment of breast reconstruction scars is important, and many procedures have been used to reduce scar formation.

Laser treatment has been consistently emphasized in recent studies for scar prevention, showing that several types of lasers, including fractional ablation lasers, are effective for reducing scar formation [6-9]. Ablative CO₂ fractional lasers (ACFLs) heat and vaporize superficial skin layers. Then, the healing process induces new collagen formation and collagen remodeling, which are responsible for scar improvement [9]. Nevertheless, few studies have evaluated the therapeutic effect of ACFLs. Moreover, recent research has begun to focus on early scar interventions. Therefore, the purpose of this study was to evaluate the efficacy of ACFL treatment for breast reconstruction scarring in the early postoperative period.

METHODS

Study design and patients

This study had a randomized, comparative, prospective, splitscar design with blinded evaluation of mastectomy scars. Between April 2019 and November 2019, 15 patients who underwent total mastectomy and immediate, implant-based breast reconstruction were treated using an ACFL (10,600 nm carbon dioxide; Lutronic Corp., Goyang, Korea) Mastectomy was performed using the same method in all patients. The incision was made from the lateral aspect to the nipple in a linear shape, and closure was based on subcutaneous buried Vicryl sutures and nylon sutures for the skin. Treatment was initiated after suture removal. Half of the scar was randomized to “A,” while the other side was allocated to “B.” Laser treatment was conducted randomly (Fig. 1). The treatment parameters ranged from 22 to 38 mJ, at a density of 300 spots/cm² in the static operating mode, mainly starting at the time of suture removal. Only one pass was made using a scan area of 4 × 4 mm in the static mode, and no other treatment (e.g., tension-relieving devices or silicone gels) was administered. After laser treatment, the patients were advised to apply hydrocolloid dressing (Duoderm; ConvaTec, Oklahoma City, OK, USA) for a 1-week. All patients provided written informed consent before participating in the trial.

Fig. 1.

Study design of the mastectomy scars. Half of each scar was randomized to “A,” while the other side was allocated to “B.” Laser treatment was conducted randomly. The red line is the mastectomy scar.

RESULTS

Fifteen patients with 15 scars completed the treatment protocol and follow-up. Table 1 shows the demographic and clinical characteristics of the study group. The average age was 43.4 years. The average length of the scar was 8.3 cm, resulting in an average treatment length of 4.2 cm.

Table 1.

Demographic and clinical characteristics of the study group

ACFL treatment improved clinical outcomes (Figs. 2, 3). The mean VSS scores were 2.20 ± 1.28 for the treatment side and 2.96 ± 1.40 for the control side. There was a significant difference in the VSS score between the treatment side and the control side (P = 0.002). The mean VAS scores were 4.13 ± 1.36 for the treatment side and 4.67 ± 1.53 for the control side. There was a significant difference in VAS scores between the treatment side and the control side (P = 0.02) (Table 2, Fig. 4). Post-therapy crusting and transient erythema were reported, but all cases resolved in 1 week. No other adverse events, including posttherapy blister formation or infection, were observed.

Fig. 2.

Clinical photograph of patient No. 2. Six months after ablative CO₂ fractional laser treatment of mastectomy scarring, the patient showed clinical improvement in the treated (T) versus the untreated scar.

Fig. 3.

Clinical photograph of patient No. 5. Six months after ablative CO₂ fractional laser treatment of mastectomy scarring, the patient showed clinical improvement in the treated (T) versus the untreated scar.

Table 2.

Mean VSS scores

Fig. 4.

Results of VSS and VAS scores. Statistically significant differences were observed in VSS and VAS scores. VSS, Vancouver scar scale; VAS, visual analog scale.

The biopsy showed well-formed dermal scar lesions in the untreated and treated cases. ACFL treatment revealed increased reticular dermal collagen deposition with normal architecture, more organized collagen fibers, and a thickened epidermis with granular layer hyperplasia and normal stratum corneum (Fig. 5). Masson’s trichrome staining revealed increased dermal collagen in the treatment group, and the collagen fibers were more regularly arranged (Fig. 6). These histologic findings are consistent with the clinical outcomes.

Fig. 5.

Histological findings. Ablative CO2 fractional laser treatment revealed increased reticular dermal collagen deposition with normal architecture; more organized collagen fibers; and a thickened epidermis with granular layer hyperplasia and a normal stratum corneum (H&E, ×40). (A) Untreated and (B) treated.

Fig. 6.

Histological findings. Masson’s trichrome staining (×40) revealed poorly structured collagen fibers on the untreated side (A) and increased dermal collagen on the treated side (B).

DISCUSSION

This was a randomized, comparative, prospective, split-scar study with blinding, in which we evaluated the effects of early ACFL treatment for mastectomy scars using VSS scores, VAS scores, and histological findings. We found that scar texture was improved by ACFL treatment, and patients’ VAS evaluations of scar appearance also showed an improvement in the treated scars compared to the untreated scars. Histopathological improvements were also observed on the treated side.

Postoperative scarring with physical sequelae (pain, itching) and the resulting psychological stress can affect not only patients’ quality of life, but also their overall satisfaction with the surgical outcomes. These scars remind patients of their illness and may be associated with functional and psychosocial morbidity [10]. Although scar remodeling and clinical improvement require at least a few years after surgery, many patients hope that the scar will be improved as soon as possible.

Many expert opinions exist regarding which laser is ideal for select indications, but there is no consensus regarding the laser type and protocol for the treatment of surgical scars. Tierney et al. [11] showed that fractional photothermolysis was superior to a pulsed dye laser for the treatment of surgical scars. Park et al. [12] reported that ablative fractional laser treatment showed profound skin changes and collagen remodeling on rats when compared to nonablative fractional laser treatment. Kim et al. [13] showed that ablative fractional laser treatment for fresh thyroidectomy scars was more effective than nonablative fractional laser treatment. We therefore hypothesized that an ablative fractional laser would be more effective for surgical scars, and chose ACFL treatment rather than a nonablative fractional laser or a pulse dye laser.

Ablative fractional lasers, which were developed to compensate for the existing shortcomings of ablative surfacing lasers, are gaining popularity in scar treatment. The fractioning characteristics of these laser beams allow healthy skin to be maintained, accelerating the healing procedure [9]. Fractional lasers create a microthermal treatment zone (MTZ). These are repeated rows of heat damage that also penetrate the upper dermis. Each ablative zone is surrounded by healthy tissue. Spared, viable keratinocytes in healthy tissue can migrate to the MTZs, where they promote the healing processes of reepithelization and collagen production [14]. Fractional lasers showed the same benefits as those obtained from ablative lasers, including dramatically reduced downtime and complications and straightforward resolution of common side effects such as erythema and edema [9]. We used pulse energy of 22–38 mJ with a total density of 300 spots/cm², and no patients developed any complications. We chose a relatively low energy level because the mastectomy skin flap was thin, and we considered the presence of the implant under the skin.

Modulation of the wound healing process may hold the key to minimize the formation of scarring. Wound healing may be divided into three overlapping phases: inflammation, proliferation, and remodeling. Traditionally, mature scars were the target of laser treatment. While laser treatment of mature scars has been shown to lead to some remodeling of scar tissue, early laser intervention for immature scars and even during wound healing has been proposed as a preventative approach to improve scar appearance. No consensus yet exists regarding the precise definition of an early intervention, but a recent systematic review defined it as laser treatment within 3 months after wound formation and found some improvement of scar appearance in 40%–75% of studies [7]. However, the proper window for laser treatment remains controversial. The current study evaluated the potential of ACFL treatment as an early intervention to improve the appearance of post-surgical scars. We treated patients with lasers within 2 to 3 weeks of surgery, at the time of suture removal, because we believed that re-epithelization would be complete at this point.

Previous reports have suggested that ACFL treatment has an effect on surgical scarring [8,15,16]. However, no studies have evaluated the therapeutic efficacy and safety of ACFL on mastectomy scars. To our knowledge, this is the first study to demonstrate clinical outcomes of ACFL treatment for mastectomy scars and safety after implant-based breast reconstruction in the early postoperative period. Furthermore, through a uniform comparison of scars, we able to prevent potential errors that may arise from differences in the scar location and suture method. However, this study also has some limitations. First, the number of samples of the patient was small. Second, while the scar formation takes at least a few years, the follow-up observations period in our study was shorter than the usual period. Third, although the histological results indicate positive effects of ACFL treatment, it should be kept in mind that the histological evaluations were done for part of the specimens, not for the whole specimens. Therefore, future studies should consider longer follow-up periods, larger sample sizes, and biopsies of all scars.

This study demonstrated that early scar treatment using ACFL showed a significant improvement in the clinical results of treatment compared to the untreated scars using VSS scores, VAS scores for patient satisfaction, and histological findings, and found that ACFL treatment had an impact on patient satisfaction. Therefore, early treatment of surgical scars with ACFL is recommended to achieve better scar cosmesis.

Article information Continued